Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/136307
Full metadata record
DC FieldValueLanguage
dc.creatorSalehi, B
dc.creatorSestito, S
dc.creatorRapposelli, S
dc.creatorPeron, G
dc.creatorCalina, D
dc.creatorSharifi-Rad, M
dc.creatorSharopov, F
dc.creatorMartins, N
dc.creatorSharifi-Rad, J
dc.date.accessioned2021-09-20T10:52:54Z-
dc.date.available2021-09-20T10:52:54Z-
dc.date.issued2019
dc.identifier.issn2218-273X
dc.identifier.urihttps://hdl.handle.net/10216/136307-
dc.description.abstractEpibatidine is a natural alkaloid that acts at nicotinic acetylcholine receptors (nAChRs). The present review aims to carefully discuss the affinity of epibatidine and its synthetic derivatives, analogues to nAChRs for a4ß2 subtype, pharmacokinetic parameters, and its role in health. Published literature shows a low affinity and lack of binding of epibatidine and its synthetic analogues to plasma proteins, indicating their availability for metabolism. Because of its high toxicity, the therapeutic use of epibatidine is hampered. However, new synthetic analogs endowed from this molecule have been developed, with a better therapeutic window and improved selectivity. All these aspects are also discussed here. On the other hand, many reports are devoted to structure–activity relationships to obtain optically active epibatidine and its analogues, and to access its pharmacological effects. Although pharmacological results are obtained from experimental studies and only a few clinical trials, new perspectives are open for the discovery of new drug therapies.
dc.description.sponsorshipThe APC was funded by N.M. Acknowledgments: Martins N. would like to thank the Portuguese Foundation for Science and Technology (FCT–Portugal) for the Strategic project reference UID/BIM/04293/2013 and “NORTE2020—Programa Operacional Regional do Norte” (NORTE-01-0145-FEDER-000012).
dc.language.isoeng
dc.publisherMDPI
dc.relationinfo:eu-repo/grantAgreement/FCT/5876/147342/PT
dc.relation.ispartofBiomolecules, vol.9(1):6
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectABT-418
dc.subjectABT-594
dc.subjectAnalgesics
dc.subjectEpibatidine
dc.subjectNicotinic acetylcholine receptors
dc.subject.meshAlkaloids
dc.subject.meshAnalgesics
dc.subject.meshAttention Deficit Disorder with Hyperactivity
dc.subject.meshBridged Bicyclo Compounds, Heterocyclic
dc.subject.meshCytochrome P-450 Enzyme System
dc.subject.meshHumans
dc.subject.meshIsoxazoles
dc.subject.meshNeurodegenerative Diseases
dc.subject.meshPyridines
dc.subject.meshPyrrolidines
dc.subject.meshQuantum Theory
dc.subject.meshReceptors, Nicotinic
dc.titleEpibatidine: A promising natural alkaloid in health
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.3390/biom9010006
dc.relation.publisherversionhttps://www.mdpi.com/2218-273X/9/1/6
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.3390-biom9010006.pdf705.49 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons